Healthcare provider profile · identity verified

Maurice Wright

Internal Medicine · WASHINGTON, DC · NPI 1396825378

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	435	175
Amlodipine Besylate	Amlodipine Besylate	387	145
Losartan Potassium	Losartan Potassium	327	120
Lisinopril	Lisinopril	190	77
Gabapentin	Gabapentin	140	51
Arexvy	Rsvpref3 Antigen/As01e/Pf	131	131
Metformin Hcl	Metformin Hcl	118	43
Pantoprazole Sodium	Pantoprazole Sodium	118	55
Furosemide	Furosemide	115	51
Hydrochlorothiazide	Hydrochlorothiazide	112	44
Levothyroxine Sodium	Levothyroxine Sodium	111	42
Wixela Inhub	Fluticasone Propion/Salmeterol	106	43
Jardiance	Empagliflozin	99	36
Tramadol Hcl	Tramadol Hcl	98	26
Carvedilol	Carvedilol	95	31
Pradaxa	Dabigatran Etexilate Mesylate	90	30
Allopurinol	Allopurinol	83	36
Hydralazine Hcl	Hydralazine Hcl	83	32
Tamsulosin Hcl	Tamsulosin Hcl	83	34
Albuterol Sulfate Hfa	Albuterol Sulfate	80	49
Famotidine	Famotidine	80	29
Pravastatin Sodium	Pravastatin Sodium	67	20
Atenolol	Atenolol	64	23
Potassium Chloride	Potassium Chloride	64	21
Spiriva Respimat	Tiotropium Bromide	62	19
Rosuvastatin Calcium	Rosuvastatin Calcium	58	24
Glipizide	Glipizide	57	23
Acetaminophen-Codeine	Acetaminophen With Codeine	55	12
Simvastatin	Simvastatin	54	23
Zolpidem Tartrate	Zolpidem Tartrate	53	13
Lorazepam	Lorazepam	51	16
Metformin Hcl Er	Metformin Hcl	51	20
Lovastatin	Lovastatin	48	19
Azelastine Hcl	Azelastine Hcl	47	20
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	44	12
Fluconazole	Fluconazole	42	30
Trazodone Hcl	Trazodone Hcl	42	12
Omeprazole	Omeprazole	40	13
Duloxetine Hcl	Duloxetine Hcl	39	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	39	20
Meloxicam	Meloxicam	38	14
Latanoprost	Latanoprost	36	13
Metoprolol Succinate	Metoprolol Succinate	35	12
Doxycycline Monohydrate	Doxycycline Monohydrate	34	26
Montelukast Sodium	Montelukast Sodium	33	11
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	32	32
Alvesco	Ciclesonide	32	15
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	31	suppressed
Ezetimibe	Ezetimibe	31	12
Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	31	14
Acyclovir	Acyclovir	29	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	29	suppressed
Levetiracetam	Levetiracetam	29	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	29	14
Triamcinolone Acetonide	Triamcinolone Acetonide	29	14
Clopidogrel	Clopidogrel Bisulfate	28	12
Finasteride	Finasteride	27	11
Donepezil Hcl	Donepezil Hcl	26	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	26	14
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	25	22
Humulin N	Insulin Nph Human Isophane	25	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	25	13
Prednisone	Prednisone	25	15
Pregabalin	Pregabalin	25	12
Celecoxib	Celecoxib	24	suppressed
Liraglutide	Liraglutide	24	suppressed
Chlorthalidone	Chlorthalidone	22	suppressed
Ibuprofen	Ibuprofen	22	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	22	suppressed
Clonidine	Clonidine	20	suppressed
Victoza 2-Pak	Liraglutide	20	suppressed
Cefuroxime	Cefuroxime Axetil	19	19
Colchicine	Colchicine	19	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	19	suppressed
Methocarbamol	Methocarbamol	19	suppressed
Tizanidine Hcl	Tizanidine Hcl	19	suppressed
Torsemide	Torsemide	19	suppressed
Fluocinonide	Fluocinonide	18	suppressed
Hydrocortisone	Hydrocortisone	18	suppressed
Naproxen	Naproxen	18	suppressed
Sucralfate	Sucralfate	18	suppressed
Terazosin Hcl	Terazosin Hcl	18	suppressed
Alprazolam	Alprazolam	17	suppressed
Azithromycin	Azithromycin	17	14
Quetiapine Fumarate	Quetiapine Fumarate	17	suppressed
Sertraline Hcl	Sertraline Hcl	17	suppressed
Alendronate Sodium	Alendronate Sodium	16	suppressed
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	16	suppressed
Lactulose	Lactulose	16	suppressed
Rabeprazole Sodium	Rabeprazole Sodium	16	suppressed
Warfarin Sodium	Warfarin Sodium	16	suppressed
Clonazepam	Clonazepam	15	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	15	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	14	suppressed
Eliquis	Apixaban	14	suppressed
Insulin Syringe	Syringe And Needle,insulin,1ml	14	suppressed
Lidocaine-Prilocaine	Lidocaine/Prilocaine	14	suppressed
Oxycodone Hcl	Oxycodone Hcl	14	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	14	suppressed
Baclofen	Baclofen	13	suppressed
Budesonide Dr	Budesonide	13	suppressed
Enoxaparin Sodium	Enoxaparin Sodium	13	suppressed
Fluticasone Propionate	Fluticasone Propionate	13	suppressed
Humulin N Kwikpen	Insulin Nph Human Isophane	13	suppressed
Metronidazole	Metronidazole	13	suppressed
Ondansetron Odt	Ondansetron	13	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	12	suppressed
Humalog Kwikpen U-100	Insulin Lispro	12	suppressed
Humulin 70/30 Kwikpen	Insulin Nph Hum/Reg Insulin Hm	12	suppressed
Labetalol Hcl	Labetalol Hcl	12	suppressed
Nifedipine Er	Nifedipine	12	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	12	12
Sumatriptan Succinate	Sumatriptan Succinate	12	suppressed
Verapamil Er	Verapamil Hcl	12	suppressed
Xarelto	Rivaroxaban	12	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	11	suppressed
Clonidine Hcl	Clonidine Hcl	11	suppressed
Morphine Sulfate Er	Morphine Sulfate	11	suppressed
Ozempic	Semaglutide	11	suppressed
Sure Comfort Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error